Mark Forchette was Appointed as Chief Executive Officer at Delphinus-Medical-Technologies

Date of management change: September 15, 2014 

What Happened?

Plymouth, MI-based Delphinus-Medical-Technologies Appointed Mark Forchette as Chief Executive Officer

 

About the Company

Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.

 

About the Person

Mr. Forchette is an accomplished medical technology executive with demonstrated success transforming industries and driving breakthrough technologies to Market leadership. Prior to joining Delphinus, Forchette was president and chief executive officer of OptiMedica Corporation, an ophthalmic medical device company that dramatically changed the standard of care in retina, glaucoma and cataract. He led the start-up venture through development and growth, successfully completed multiple rounds of financing, and oversaw the company`s acquisition by Abbott Laboratories in 2013. He began his career in the medical technology industry as a sales representative at Greishaber and Company, Inc., where he ultimately became vice president of U.S. sales and Marketing and led the company through its acquisition by Alcon. During his tenure at Alcon, he steered the tactical integration of Grieshaber, advanced to Vice President of vitreoretinal sales and global Marketing, and led the retina portfolio through substantial Market share gain. Mr. Forchette has a bachelor`s degree in Marketing from Auburn University and completed the Harvard Program for Management Development. He is currently on the Dean`s Advisory Board of the Harbert College of Business at Auburn and is a member of the board of directors of VisionCare Technologies in Saratoga, California.  

 

Info Source

Press Release

 
 

Other IT executives who recently changed jobs as well: Fredricksen Clark, Brienza Suzanne, Peters Kelly, Citrone Mark, Katz Jill, Iannuzzo Ali, Jacobs Carrie, Wheeler Pamela, Clementi Tony, Hine Lisa, Rassatt Kylie

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.